Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Licenses Broad IP for Genome Partitioning Technology

NEW YORK (GenomeWeb News) – Agilent Technologies has licensed genome partitioning technology from the Broad Institute that will aid in linking genes to diseases, the company said today.
 
The company plans to use the technology to develop genome-partitioning kits that will incorporate the company’s Oligo Library Synthesis technology.
 
“We’re working on a simple, highly multiplexed, cost-effective way to enable investigators to remove the sample-preparation bottleneck in sequencing targeted regions of mammalian genomes, using relatively small amounts of input DNA,” said Chad Nusbaum, who is co-director of the Genome Sequencing and Analysis Program at the Broad Institute.
 
“This work to eliminate the sample-preparation bottleneck of next-generation sequencing will greatly accelerate our understanding of how genes operate,” said Agilent VP and GM of Genomics Yvonne Linney.
 
Financial terms of the agreement were not released.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.